COVID-19 vaccination in our transplant recipients: The time is now

Saima Aslam, Daniel R. Goldstein, Robin Vos, Andrew E. Gelman, Michelle M. Kittleson, Cameron Wolfe, Lara Danziger-Isakov

Research output: Contribution to journalEditorial

47 Scopus citations


We are entering 2021 with an expanding and effective COVID-19 vaccine armamentarium. Recent interim results from COVID-19 vaccine trials, including more than 80,000 participants worldwide, demonstrate remarkable efficacy and low rate of serious adverse events. Based on experience with other vaccines in transplant recipients and knowing the risk of severe COVID-19 in this population, we believe that COVID-19 vaccines provide potential benefit with minimal risk. We strongly support and encourage COVID-19 vaccination of our transplant recipients.

Original languageEnglish
Pages (from-to)169-171
Number of pages3
JournalJournal of Heart and Lung Transplantation
Issue number3
StatePublished - Mar 2021


  • COVID-19
  • SARS-CoV-2
  • pandemic
  • transplant
  • vaccination
  • vaccine


Dive into the research topics of 'COVID-19 vaccination in our transplant recipients: The time is now'. Together they form a unique fingerprint.

Cite this